Editorial: Privacy enhancing technology: a top 10 emerging technology to revolutionize healthcare
-
By
-
Lisette J. E. van Gemert-Pijnen
-
Thijs Veugen
-
March 25, 2026
Clinical Scorecard: Transformative Potential of Privacy-Enhancing Technologies in Healthcare Among 2024's Top Ten Emerging Innovations
At a Glance
| Category | Detail |
|---|---|
| Condition | Privacy and data security challenges in healthcare data utilization |
| Key Mechanisms | Privacy-Enhancing Technologies (PETs) including federated learning, synthetic data generation, differential privacy, homomorphic encryption, and zero-knowledge proofs |
| Target Population | Healthcare institutions, researchers, policymakers, and patients involved in data-driven healthcare |
| Care Setting | Healthcare data management across institutions and nations, including clinical research and personalized medicine |
Key Highlights
- PETs enable secure, privacy-preserving data sharing and analysis across multiple healthcare institutions without centralizing sensitive data.
- Synthetic data generation and differential privacy support compliance with regulations like GDPR and HIPAA while facilitating research and AI model training.
- Challenges include maintaining data quality, mitigating bias, computational demands, and aligning with evolving legal and ethical frameworks such as the European Health Data Space.
Guideline-Based Recommendations
Diagnosis
- Utilize federated learning protocols to combine multi-institutional data for improved predictive modeling without compromising patient privacy.
Management
- Implement synthetic data generation techniques to augment scarce datasets, especially for rare disease research, ensuring regulatory compliance.
- Adopt privacy-by-design principles embedding PETs from the outset of healthcare technology development.
- Leverage cloud-based platforms and emerging AI technologies (GANs, VAEs) to manage computational overhead.
Monitoring & Follow-up
- Ensure transparency through algorithmic audits, third-party reviews, and domain expert evaluations to maintain data validity and quality.
- Monitor reidentification risks and compliance with data protection regulations continuously.
Risks
- Potential loss of data nuances affecting research validity when using synthetic data alone; consider hybrid models combining real and synthetic data.
- Societal risks including reinforcing disparities and inconsistent definitions across jurisdictions leading to misinterpretations.
- Technological and legal barriers (LEFT aspects) hindering PET implementation.
Patient & Prescribing Data
Patients whose data are used in multi-institutional healthcare research and personalized medicine initiatives
PETs facilitate secure data sharing and analysis that can improve precision medicine approaches while safeguarding patient privacy and complying with data protection laws.
Clinical Best Practices
- Apply federated and privacy-preserving machine learning methods to enable collaborative research without data centralization.
- Use synthetic data generation cautiously, validating quality and combining with real data to preserve clinical relevance.
- Incorporate differential privacy adapted for temporal and correlated healthcare data such as ECG records.
- Engage multi-stakeholder collaborations including PET experts, policymakers, industry, and healthcare professionals to develop standards and governance.
- Embed privacy-by-design principles early in healthcare technology development to ensure data protection is integral.
- Invest in computational infrastructure and emerging AI techniques to support scalable PET applications.
References
- World Economic Forum Top Ten Emerging Technologies 2024
- European Health Data Space (EHDS) Policy Initiative
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.